Internet of Things & Industrial Internet

Pasi Kemppainen


Pasi Kemppainen NDBS

Pasi Kemppainen is entrepreneur and executive consultant for pharmaceutical industrial internet strategy and implementation covering primary and secondary manufacturing, supply chain and IT.
Previously, he served as Chief Executive Officer at Original1 GmbH (a joint venture of SAP, Nokia and Giesecke&Devrient – leaders in enterprise IT, mobile and security) servicing a cloud platform for product serialization, traceability and consumer authentication in pharmaceutical, consumer goods and manufacturing industries. In China, Original1 commercialized the world’s first mobile drug traceability and authentication service for consumers.

Prior to Original1, Pasi headed Nokia Authentication Solution business in Nokia China empowering consumers and businesses to authenticate product originality and counterfeits using their mobile phones. The products covered consumer products, drugs and ID cards and ultimately the solution was selected as the best anti-counterfeit solution in China by China RFID Journal and China Anti-counterfeit Association. Before heading Nokia Authentication Solution business, he led the incubation of new technologies and businesses at Nokia Ventures Organization.
IQPC Pharma, the leading pharmaceutical event organizer, has named Pasi as one of the thought leaders in pharmaceutical serialization and traceability in 2014. He is a featured speaker and chairman in pharmaceutical industry events.

Pasi is working on the doctorate dissertation on pharmaceutical industrial internet technology and business disruption at Lappeenranta University of Technology Faculty of Industrial Engineering and Management.

Industrial IoT Changing Traditional Business Dynamics: Case Pharmaceutical Industry

There is a huge hype around Internet of Things at the moment. Technology-wise IoT is not that much new; connected sensors and machines providing visibility to their operation have been around for quite some time.

However, fundamental changes will take place on a system level, with re-engineered workflows and totally new business dynamics as well as business models. We have seen incumbent industries such as financial services or transportation being disrupted by totally new and unexpected players who were born digital. To maintain their competitiveness in the rapidly changing business environment, traditional companies need to start acting on much faster clock rate, challenging their status quo.

Sampo and Pasi will discuss about technology and ecosystem disruption in conservative industries by using pharmaceutical industry as a concrete example.